Online citations, reference lists, and bibliographies.
← Back to Search

Perturbations In The Fibrinolytic Pathway Abolish Cyst Formation But Not Capillary-like Organization Of Cultured Murine Endothelial Cells.

N. Dubois-stringfellow, A. Jonczyk, V. Bautch
Published 1994 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Fibrinolytic activity and its relation to morphogenesis was investigated in several transformed murine endothelial cell lines and primary cultures of endothelial cells. Two in vitro systems, fibrin gels and Matrigel (Collaborative Research, Bedford, MA), were used. Fibrin gels model a fibrin-rich extracellular matrix that frequently supports neovascularization in vivo, and Matrigel models the basement membrane surrounding quiescent endothelial cells in vivo. The transformed endothelial cell lines have higher levels of plasminogen activator (PA) mRNA than primary cultures of endothelial cells, and an increased PA-mediated proteolytic activity was correlated with formation of cysts in fibrin gels. Addition of neutralizing anti-urokinase antibodies, plasminogen depletion, or addition of a plasmin inhibitor prevented cyst formation. Addition of plasminogen restored the ability to form cysts in the plasminogen-depleted system. Normal endothelial cells organized into capillary-like structures in fibrin gels regardless of manipulations affecting the fibrinolytic pathway. In Matrigel, both transformed and primary cultures of endothelial cells rapidly formed a capillary-like network that was not affected by plasminogen depletion or addition of plasmin inhibitors. Thus, elements of the fibrinolytic pathway necessary for cyst formation are not critical in capillary-like structure formation on a reconstituted basement membrane. These results suggest that plasmin is essential for hemangioma formation but is not critical to the organizational behavior of normal endothelial cells.
This paper references
10.1159/000158667
Heterogeneity of Mouse Vascular Endothelium
F. Gumkowski (1987)
10.1016/0092-8674(91)90642-C
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
L. Liotta (1991)
10.1083/JCB.104.5.1281
Plasminogen activator and mouse spermatozoa: urokinase synthesis in the male genital tract and binding of the enzyme to the sperm cell surface
J. Huarte (1987)
10.1016/S0309-1651(85)90107-9
Vascular outgrowths from tissue explants embedded in fibrin or collagen gels: a simple in vitro model of angiogenesis.
R. Montesano (1985)
A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology.
J. Obeso (1990)
10.2491/JJSTH1970.9.28
Blood Coagulation, Fibrinolysis and their Inhibitors Studies on Patients with Cancer
Hisashi Beppu (1978)
The involvement of proteases and protease inhibitors in neovascularization.
D. Rifkin (1981)
Biological properties of plasminogen activators
D Collen
10.1016/0014-4827(82)90244-0
The effect of proteases on endothelial cell migration in vitro.
R. Schleef (1982)
10.1126/SCIENCE.6190230
Basement membrane collagen: degradation by migrating endothelial cells.
T. Kalebic (1983)
10.1016/0005-2744(79)90256-0
Plasminogen activator from cells transformed by an oncogenic virus: inhibitors of the activation reaction.
K. Danø (1979)
10.1016/0092-8674(90)90009-4
Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene
R. Montesano (1990)
10.1083/JCB.108.2.671
In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases
P. Mignatti (1989)
10.1016/0092-8674(90)90010-C
Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator
J. Heckel (1990)
10.1002/JCP.1041250102
Fibrin‐enhanced endothelial cell organization
J. Olander (1985)
10.1016/0223-5234(87)90281-9
Tissue Plasminogen Activator in Thrombolytic Therapy
B. Sobel (1987)
Endothelial
VL Bautch
10.1002/JCP.1041320313
Phorbol ester induces cultured endothelial cells to invade a fibrin matrix in the presence of fibrinolytic inhibitors
R. Montesano (1987)
10.1073/PNAS.83.19.7297
Basic fibroblast growth factor induces angiogenesis in vitro.
R. Montesano (1986)
10.1016/0092-8674(74)90097-X
Increased protease levels in transformed cells: a casein overlay assay for the detection of plasminogen activator production.
A. Goldberg (1974)
10.1093/JNCI/62.6.1459
Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression.
H. Dvorak (1979)
10.1002/JCP.1041360309
Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells
S. Yagel (1988)
10.1016/0167-4838(82)90068-1
Studies on the kinetics of plasminogen activation by tissue plasminogen activator.
M. Rånby (1982)
10.1055/S-0038-1650126
Isolation and properties of human vascular plasminogen activator.
R. Allen (1981)
Blood coagulation, fibrinolysis and cancer, in Francis JL (ed): Fibrinogen, Fibrin Stabilisation and Fibrinolysis
NLM Goeting (1988)
10.1016/s0021-9258(19)57341-0
Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation.
R. Rickles (1988)
10.1016/0092-8674(83)90093-4
Antibodies to plasminogen activator inhibit human tumor metastasis
L. Ossowski (1983)
10.1002/9783527618330
Handbook of Enzyme Inhibitors
H. Zollner (1989)
10.1016/0092-8674(89)90343-7
Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment
R. Williams (1989)
10.1083/JCB.107.4.1589
Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures
Y. Kubota (1988)
10.1055/S-2007-1003527
Fibrinolytic pathways and the endothelium.
C. Hekman (1987)
10.1083/JCB.97.1.153
Capillary endothelial cell cultures: phenotypic modulation by matrix components
J. Madri (1983)
10.1172/JCI115405
The plasminogen activator/plasmin system.
J. D. Vassalli (1991)
expressing the middle T oncogene
NA Dubois (1990)
10.1084/JEM.159.6.1653
Concomitant secretion of prourokinase and of a plasminogen activator- specific inhibitor by cultured human monocytes-macrophages
J. D. Vassalli (1984)
10.1007/978-1-4613-2825-4_20
Properties of plasminogen activators produced by endothelial cells
D. Loskutoff (1984)
Regulation of the synthesis and secretion of plasminogen activators by endothelial cells.
V. V. van Hinsbergh (1988)
10.1021/BI00267A025
Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma.
H. Kleinman (1982)
10.1016/0092-8674(77)90272-0
Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids
A. Berk (1977)
10.1016/0092-8674(87)90122-X
Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene
V. Bautch (1987)
Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.
P. Quax (1990)
10.1111/J.1432-1033.1985.TB08829.X
Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator.
D. Belin (1985)
10.1159/000215814
Regulation of the Synthesis and Secretion of Plasminogen Activators by Endothelial Cells
V. Hinsbergh (1988)
10.1016/S0065-230X(08)60028-7
Plasminogen activators, tissue degradation, and cancer.
K. Danø (1985)
10.1111/J.1432-0436.1989.TB00606.X
Phenotypic comparison between mesothelial and microvascular endothelial cell lineages using conventional endothelial cell markers, cytoskeletal protein markers and in vitro assays of angiogenic potential.
N. Chung-Welch (1989)
10.1083/JCB.111.2.743
Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro
M. Pepper (1990)
10.1016/s0021-9258(18)34566-6
A proenzyme form of human urokinase.
T. Wun (1982)
Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells
JA Mourik (1983)
10.1016/0304-419X(88)90005-4
Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis.
D. Moscatelli (1988)
10.1083/JCB.115.4.1107
In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion
L. Ossowski (1991)
Studies on the temporal correlation between secretion of plasminogen activator and stages of early mouse embryogenesis.
M. I. Sherman (1980)
10.1161/01.ATV.7.4.389
Production of Plasminogen Activators and Inhibitor by Serially Propagated Endothelial Cells from Adult Human Blood Vessels
V. W. Hinsbergh (1987)
10.1083/JCB.94.3.511
Organizational behavior of human umbilical vein endothelial cells
T. Maciag (1982)
Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
Y. Sakata (1988)
10.1111/j.1749-6632.1960.tb42862.x
REACTIONS TO HOMOLOGOUS AND HETEROLOGOUS FIBRIN IMPLANTS IN EXPERIMENTAL ANIMALS
S. Banerjee (1960)
Plasminogen activator (urokinase) causes vascularization of the cornea.
M. Berman (1982)
10.1126/science.170.3962.1095
Plasminogen: Purification from Human Plasma by Affinity Chromatography
D. Deutsch (1970)
10.1038/288551A0
Angiogenesis in vitro
J. Folkman (1980)
10.1016/0014-4827(91)90265-V
Isolation and characterization of an established endothelial cell line from transgenic mouse hemangiomas.
N. A. Dubois (1991)
Heterogeneity of mouse vascular endothelium. Blood Vessels
F Gumkowski (1987)
10.1002/JCP.1041500206
Urokinase‐type plasminogen activator mediates basic fibroblast growth factor‐induced bovine endothelial cell migration independent of its proteolytic activity
L. E. Odekon (1992)
10.1083/JCB.94.3.631
Cultured bovine endothelial cells produce both urokinase and tissue- type plasminogen activators
E. G. Levin (1982)
10.1016/0012-1606(88)90225-4
Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis.
W. Risau (1988)
10.1073/PNAS.80.10.2956
Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.
D. Loskutoff (1983)



This paper is referenced by
ANGIOGENESIS AND THE MODELS TO STUDY ANGIOGENESIS
M. Ali (2010)
10.1152/AJPCELL.00101.2004
Role of TGF-β1 and JNK signaling in capillary tube patterning
K. Bein (2004)
Endothelial miR-30 c suppresses tumor growth via inhibition of TGF-b – induced Serpine 1
James V. McCann (2019)
10.1023/A:1009095825561
The urokinase plasminogen activator system in cancer: Implications for tumor angiogenesis and metastasis
A. Mazar (2004)
Design of a microreactor for studying the effect of shear stress on angiogenesis in self-assembling peptide matrix
Jennifer T. Blundo (2004)
10.1016/S1055-3207(18)30072-3
The role of the plasminogen activation system in angiogenesis and metastasis.
S. Rabbani (2001)
10.1038/labinvest.3780252
In Vitro Models of Vasculogenesis and Angiogenesis
B. Vailhé (2001)
10.1172/JCI123106
Endothelial miR-30c suppresses tumor growth via inhibition of TGF-&bgr;–induced Serpine1
James V. McCann (2019)
10.1007/S00285-003-0262-2
Mathematical modeling of tumor-induced angiogenesis
Nikos V. Mantzaris (2004)
Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
H. Y. Min (1996)
10.1046/j.1365-2141.1997.3163133.x
Murine endothelial cells support fetal liver erythropoiesis and myelopoiesis via distinct interactions
O. Ohneda (1997)
10.1007/978-3-642-61107-0_3
Plasminogen activators and angiogenesis.
P. Mignatti (1996)
MINIREVIEW In Vitro Models of Vasculogenesis and Angiogenesis
B. Vailhé (2001)
10.1007/s11626-997-0155-6
In vitro angiogenesis is modulated by the mechanical properties of fibrin gels and is related to αvβ3 integrin localization
B. Vailhé (1997)
10.1161/HQ0701.093685
Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis
M. Pepper (2001)
10.1023/A:1009238717101
The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors
B. Vailhé (2004)
10.1055/S-0037-1614439
Hemostasis in the mouse (Mus musculus): a review.
D. Tsakiris (1999)
10.1097/01.prs.0000277661.49581.c9
A Novel In Vivo Model of Human Hemangioma: Xenograft of Human Hemangioma Tissue on Nude Mice
Y. Tang (2007)
10.1007/978-1-4615-0165-7_16
Role of the Plasminogen Activator-Plasmin System in Angiogenesis
M. Pepper (2003)
10.1007/978-1-4615-0165-7
Plasminogen: Structure, Activation, and Regulation
D. M. Waisman (2003)
10.1083/JCB.137.4.953
Polyoma Middle T-induced Vascular Tumor Formation: The Role of the Plasminogen Activator/Plasmin System
K. Sabapathy (1997)
Semantic Scholar Logo Some data provided by SemanticScholar